Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mexidol in Acute Hemispheric Ischemic Stroke (EPICA)
NCT02793687Phase 3Completed
- Sponsor
- Pharmasoft
- Start
- Mar 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Mexidol with Placebo (2 arms). Primary endpoint: Modified Rankin Scale. Started Mar 2015; status: completed.
02
Drugs
emoxypine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02793687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02793687.